Thompson Davis & Co’s Conformis, Inc. Common Stock CFMS Stock Holding History

Thompson Davis & Co’s Portfolio CFMS Stock Details CFMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-424	Closed	-$7K	–	124
2022 Q1	$7K	Sell	424 -40	-9%	-$657	0.01%	102
2021 Q4	$9K	Buy	+464	New	+$11.9K	0.01%	122
2018 Q3	$3K	Sell	120 -73	-38%	-$1.99K	0.01%	645
2018 Q2	$6K	Buy	193 +133	+222%	+$4.6K	0.01%	505
2018 Q1	$2K	Hold	60	–	–	0.01%	582
2017 Q4	$4K	Buy	60 +40	+200%	+$3.2K	0.01%	558
2017 Q3	$2K	Hold	20	–	–	﹤0.01%	1027
2017 Q2	$2K	Sell	20 -20	-50%	-$2.4K	﹤0.01%	1012
2017 Q1	$5K	Sell	40 -410	-91%	-$69.4K	0.01%	905
2016 Q4	$91K	Buy	450 +430	+2,150%	+$95.2K	0.15%	150
2016 Q3	$5K	Buy	+20	New	+$4.02K	0.01%	851
2015 Q4	–	Sell	-5	Closed	-$2K	–	1210
2015 Q3	$2K	Buy	+5	New	+$2.52K	﹤0.01%	1041

Other funds holding CFMS

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thompson Davis & Co's CFMS Position: Q2 2022 in Review

Thompson Davis & Co sold out of Conformis, Inc. Common Stock (CFMS) in Q2 2022, closing a stake of 424 shares — an estimated $7K sold.

Thompson Davis & Co first reported a position in CFMS in Q3 2015 and held it in 12 quarters. The position peaked at $91K in Q4 2016. 81 funds tracked by Wall St. Rank hold CFMS as of Q2 2022.

Thompson Davis & Co reported no remaining Conformis, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Thompson Davis & Co sold 424 Conformis, Inc. Common Stock shares in Q2 2022, an estimated $7K.
Thompson Davis & Co first reported a position in Conformis, Inc. Common Stock in Q3 2015 and held it in 12 quarters.
Thompson Davis & Co's Conformis, Inc. Common Stock position peaked at $91K in Q4 2016.
81 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q2 2022.

Based on Thompson Davis & Co's 13F filing for Q2 2022, filed 2 Aug 2022.